Cytosite Bio
Pre-clinicalWe’re revolutionizing immunotherapy by harnessing the power of granzyme B to transform cancer and autoimmune disease treatments.[I]Investigational status. CSB-321 and CSB-421 are investigational product candidates. They have not been approved by the U.S. FDA or any other regulatory authority for safety or efficacy. Any references to potential clinical utility reflect development goals only. Our PET imaging radiodiagnostic can provide early mechanistic insights[II]Biomarker / imaging purpose. ...
Private Company
Funding information not available
About
We’re revolutionizing immunotherapy by harnessing the power of granzyme B to transform cancer and autoimmune disease treatments.[I]Investigational status. CSB-321 and CSB-421 are investigational product candidates. They have not been approved by the U.S. FDA or any other regulatory authority for safety or efficacy. Any references to potential clinical utility reflect development goals only. Our PET imaging radiodiagnostic can provide early mechanistic insights[II]Biomarker / imaging purpose. ...